DCF — ST. JOHNS REGIONAL MEDICAL CENTER
Enterprise Value: $-1.0B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.0B
Enterprise Value
$-320.2M
PV of Cash Flows
$-699.0M
PV of Terminal Value
$-1.1B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $570.0M | $-64.7M | -11.0% | $-88.9M | $-80.8M |
| Year 2 | $587.1M | $-60.8M | -10.0% | $-85.7M | $-70.8M |
| Year 3 | $604.7M | $-56.6M | -9.0% | $-82.2M | $-61.7M |
| Year 4 | $622.8M | $-55.2M | -9.0% | $-81.5M | $-55.7M |
| Year 5 | $641.5M | $-55.2M | -9.0% | $-82.4M | $-51.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.0B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$553.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.11857183898795304
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5